New patent for Biocryst drug ORLADEYO

September 9, 2021 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for ORLADEYO Orladeyo is a drug marketed by Biocryst and is included in one NDA. There are four patents protecting this drug. This drug has thirty-six…

The post New patent for Biocryst drug ORLADEYO appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.